What Is Mycophenolate Mofetil? Uses, Dosage, and What You Need to Know in 2026

Mycophenolate mofetil is one of the most widely prescribed immunosuppressants in the world, yet many patients taking it have limited information about why they're on it, how it works, and what to expect. If you or someone you care for is taking mycophenolate mofetil (brand name CellCept), this comprehensive guide covers everything you need to know.

What Is Mycophenolate Mofetil?

Mycophenolate mofetil (MMF) is an immunosuppressant drug — a medication that reduces the activity of the immune system. It belongs to a class of drugs called selective IMPDH (inosine monophosphate dehydrogenase) inhibitors. The brand name is CellCept (Genentech/Roche), and it's also available as a generic from multiple manufacturers.

MMF was first approved by the FDA in 1995 for kidney transplant rejection prevention, making it one of the foundational drugs in modern transplant medicine. In the decades since, its use has expanded significantly to include a wide range of autoimmune conditions.

What Is Mycophenolate Mofetil Used For?

FDA-approved uses (on-label) include:

• Prevention of kidney transplant rejection in adults and children (≥3 months of age)
• Prevention of heart transplant rejection in adults and children (≥3 months of age)
• Prevention of liver transplant rejection in adults and children (≥3 months of age)

Common off-label uses (prescribed without FDA approval but supported by clinical evidence) include:

• Systemic lupus erythematosus (SLE) and lupus nephritis
• ANCA-associated vasculitis (granulomatosis with polyangiitis, microscopic polyangiitis)
• Myasthenia gravis
• Systemic sclerosis (scleroderma) — particularly lung involvement
• Pemphigus vulgaris and bullous pemphigoid
• IgA nephropathy and other glomerular diseases
• Inflammatory bowel disease (Crohn's disease, ulcerative colitis — as a steroid-sparing agent)

What Dosage Forms Is Mycophenolate Mofetil Available In?

Mycophenolate mofetil is available in four forms:

• 250 mg capsules — Blue-brown gelatin capsules (brand CellCept labeled 'CellCept 250'); common in transplant dosing
• 500 mg tablets — Lavender film-coated tablets (brand CellCept labeled 'CellCept 500'); most commonly prescribed form
• 200 mg/mL oral suspension — Liquid formulation; Myhibbin (Azurity Pharmaceuticals) is a ready-to-use version FDA-approved in 2024 for patients who cannot swallow solid forms, including children ≥3 months
• 500 mg IV formulation — Used in hospital settings when oral formulations are not feasible (e.g., immediately post-transplant surgery); infused over at least 2 hours

What Are the Standard Doses?

Doses vary by indication:

• Kidney transplant (adults): 1 g twice daily (2 g/day total)
• Heart or liver transplant (adults): 1.5 g twice daily (3 g/day total)
• Autoimmune diseases (adults): Typically 2-3 g/day in divided doses (e.g., 1–1.5 g twice daily); often started lower and titrated up based on response and tolerability
• Pediatric kidney transplant: 600 mg/m² BSA twice daily (maximum 2 g/day or 10 mL oral suspension)

How Should You Take It?

Key directions for taking mycophenolate mofetil:

• Take on an empty stomach (1 hour before or 2 hours after food) unless your provider tells you otherwise
• Do not crush tablets or open capsules — the powder is hazardous to skin and mucous membranes. If contact occurs, wash thoroughly with soap and water
• If you miss a dose, take it as soon as you remember — unless your next dose is less than 2 hours away, in which case skip the missed dose and continue on schedule. Never double dose.
• Do not stop taking mycophenolate mofetil without your provider's direction — stopping suddenly can have serious consequences for transplant recipients and autoimmune patients

Is Mycophenolate Mofetil a Controlled Substance?

No. Mycophenolate mofetil is not a controlled substance and has no DEA schedule. It does not have addiction potential or abuse potential. It requires a standard prescription but can be transferred to a different pharmacy, filled early (within insurance/Rx limits), and sent via mail-order without any of the restrictions that apply to controlled substances.

What Monitoring Is Required?

Regular blood and urine monitoring is essential while on MMF. Your provider will check CBC with differential (for blood cell count abnormalities), complete metabolic panel (for kidney and liver function), and urinalysis. Transplant patients typically have additional monitoring including drug levels for co-administered tacrolimus or cyclosporine.

If you ever have trouble filling your mycophenolate mofetil prescription due to pharmacy stock issues, medfinder can locate pharmacies near you that have it in stock.

For a deep dive into how the drug works, see: How Does Mycophenolate Mofetil Work? Mechanism of Action Explained. For side effects: Mycophenolate Mofetil Side Effects: What to Expect and When to Call Your Doctor.